Literature DB >> 13679651

The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability.

H C Hemker1, P Giesen, R AlDieri, V Regnault, E de Smed, R Wagenvoord, T Lecompte, S Béguin.   

Abstract

By using a "slow" fluorogenic thrombin substrate and continuous comparison to a simultaneously run calibrator, thrombin generation can be monitored automatically, on line, in clotting PPP or PRP at a throughput of up to 100 samples per hour. The resulting "Thrombogram" in PPP measures hypocoagulability (haemophilias, oral anticoagulants, heparins (-likes), direct inhibitors) and hypercoagulabilities (AT deficiency, prothrombin hyperexpression, prot. C and S deficiency, factor V Leiden, oral contraceptives). In PRP it is diminished in thrombopathies, in von Willebrand disease, by antibodies blocking GPIIb-IIIa or GPIb, or by antiplatelet drugs like aspirin and clopidogrel. Lupus anticoagulant both retards and increases thrombin generation. The thrombogram thus appears to be a broad function test of the haemostatic-thrombotic mechanism of the blood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 13679651     DOI: 10.1159/000073575

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  135 in total

1.  Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.

Authors:  Vikas Bhat; Annette von Drygalski; Andrew J Gale; John H Griffin; Laurent O Mosnier
Journal:  Thromb Haemost       Date:  2015-10-15       Impact factor: 5.249

2.  Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Authors:  Carolyn L Westhoff; Malcolm C Pike; Serge Cremers; Andrew Eisenberger; Stella Thomassen; Jan Rosing
Journal:  Contraception       Date:  2017-01-11       Impact factor: 3.375

3.  Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke.

Authors:  Victor Serebruany; Yanti Sani; Donald Lynch; Alex Schevchuck; Stan Svetlov; Alan Fong; Lionel Thevathasan; Dan Hanley
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

4.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

5.  Thrombin generation and bleeding in haemophilia A.

Authors:  K E Brummel-Ziedins; M F Whelihan; M Gissel; K G Mann; G E Rivard
Journal:  Haemophilia       Date:  2009-06-26       Impact factor: 4.287

Review 6.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

7.  Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant.

Authors:  A von Drygalski; T J Cramer; V Bhat; J H Griffin; A J Gale; L O Mosnier
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

8.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

9.  Tissue factor-dependent thrombin generation across pregnancy.

Authors:  Kelley C McLean; Ira M Bernstein; Kathleen E Brummel-Ziedins
Journal:  Am J Obstet Gynecol       Date:  2012-06-11       Impact factor: 8.661

10.  The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.

Authors:  D Zamolodchikov; T Renné; S Strickland
Journal:  J Thromb Haemost       Date:  2016-02-29       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.